{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:15:39Z","timestamp":1769825739645,"version":"3.49.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8,1]]},"DOI":"10.1097\/01.qai.0000167478.28051.3a","type":"journal-article","created":{"date-parts":[[2005,6,22]],"date-time":"2005-06-22T08:03:08Z","timestamp":1119427388000},"page":"395-400","source":"Crossref","is-referenced-by-count":99,"title":["Redefining Lipodystrophy Syndrome"],"prefix":"10.1097","volume":"39","author":[{"given":"Kenneth A","family":"Lichtenstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-4-20210131","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R4-4-20210131","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00002030-199912240-00002","article-title":"Fat distribution and metabolic changes in patients with HIV infection.","volume":"13","author":"Safrin","year":"1999","journal-title":"AIDS"},{"key":"R5-4-20210131","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"An objective case definition of lipodystrophy in HIV-infected adults: a case-control study.","volume":"361","author":"Carr","year":"2003","journal-title":"Lancet"},{"key":"R6-4-20210131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","article-title":"HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.","volume":"4","author":"Miller","year":"2003","journal-title":"HIV Med"},{"key":"R7-4-20210131","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200301010-00007","article-title":"Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients.","volume":"32","author":"Lichtenstein","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-4-20210131","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"R9-4-20210131","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00042560-200208010-00010","article-title":"Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based cohort.","volume":"30","author":"Heath","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-4-20210131","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1086\/339866","article-title":"Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.","volume":"34","author":"Saves","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R11-4-20210131","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/317477","article-title":"Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe dEpidemiologie Clinique du Syndrome dImmunodeficience Acquise en Aquitaine.","volume":"31","author":"Thiebaut","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R12-4-20210131","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"R13-4-20210131","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-200212060-00010","article-title":"Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trails.","volume":"16","author":"Joly","year":"2002","journal-title":"AIDS"},{"key":"R14-4-20210131","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00042560-200107010-00004","article-title":"Stavudine versus zidovudine and the development of lipodystrophy.","volume":"27","author":"Bogner","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-4-20210131","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy.","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"key":"R16-4-20210131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00126334-200309010-00008","article-title":"Gender differences in antiretroviral drug-related adipose tissue alterations: women are at higher risk than men and develop particular lipodystrophy patterns.","volume":"34","author":"Galli","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R18-4-20210131","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200109280-00010","article-title":"HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study.","volume":"15","author":"Carr","year":"2001","journal-title":"AIDS"},{"key":"R21-4-20210131","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance.","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"R24-4-20210131","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","article-title":"Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.","volume":"25","author":"Mynarcik","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-4-20210131","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/00002030-200210180-00005","article-title":"TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy.","volume":"16","author":"Maher","year":"2002","journal-title":"AIDS"},{"key":"R26-4-20210131","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0022-2275(20)34890-2","article-title":"Monogenic disorders of obesity and body fat distribution.","volume":"40","author":"Chen","year":"1999","journal-title":"J Lipid Res"},{"key":"R27-4-20210131","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV- infected patients.","volume":"346","author":"Cote","year":"2002","journal-title":"N Engl J Med"},{"key":"R28-4-20210131","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"R29-4-20210131","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00002030-199911120-00019","article-title":"Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy.","volume":"13","author":"Kakuda","year":"1999","journal-title":"AIDS"},{"key":"R31-4-20210131","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00002030-200109280-00009","article-title":"Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.","volume":"15","author":"Shikuma","year":"2001","journal-title":"AIDS"},{"key":"R32-4-20210131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00042560-200202010-00002","article-title":"Evidence of nucleoside analogue reverse transcriptase inhibitor-associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients.","volume":"29","author":"Walker","year":"2002","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.qai.0000167478.28051.3a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:24:21Z","timestamp":1621887861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200508010-00004"}},"subtitle":["Risks and Impact on Clinical Decision Making"],"short-title":[],"issued":{"date-parts":[[2005,8,1]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.qai.0000167478.28051.3a","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8,1]]}}}